oseltamivir phosphate for oral suspension

Generic: oseltamivir phosphate

Labeler: oryza pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oseltamivir phosphate for oral suspension
Generic Name oseltamivir phosphate
Labeler oryza pharmaceuticals inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

oseltamivir phosphate 6 mg/mL

Manufacturer
Oryza Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 72516-029
Product ID 72516-029_4627bcf0-5295-1d6d-e063-6394a90ab3ce
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217303
Listing Expiration 2026-12-31
Marketing Start 2025-10-19

Pharmacologic Class

Classes
neuraminidase inhibitor [epc] neuraminidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72516029
Hyphenated Format 72516-029

Supplemental Identifiers

RxCUI
1115698
UPC
0372516029012
UNII
4A3O49NGEZ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oseltamivir phosphate for oral suspension (source: ndc)
Generic Name oseltamivir phosphate (source: ndc)
Application Number ANDA217303 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, GLASS in 1 CARTON (72516-029-01) / 60 mL in 1 BOTTLE, GLASS
source: ndc

Packages (1)

72516-029-01 1 BOTTLE, GLASS in 1 CARTON (72516-029-01) / 60 mL in 1 BOTTLE, GLASS

Ingredients (1)

oseltamivir phosphate (6 mg/mL)

Linked Drug Pages (1)

Oseltamivir Phosphate for Oral Suspension ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4627bcf0-5295-1d6d-e063-6394a90ab3ce", "openfda": {"upc": ["0372516029012"], "unii": ["4A3O49NGEZ"], "rxcui": ["1115698"], "spl_set_id": ["11cf45d4-0e6c-4408-bbe6-5ed94468cf2e"], "manufacturer_name": ["Oryza Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (72516-029-01)  / 60 mL in 1 BOTTLE, GLASS", "package_ndc": "72516-029-01", "marketing_start_date": "20251019"}], "brand_name": "Oseltamivir Phosphate for Oral Suspension", "product_id": "72516-029_4627bcf0-5295-1d6d-e063-6394a90ab3ce", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "72516-029", "generic_name": "Oseltamivir Phosphate", "labeler_name": "Oryza Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oseltamivir Phosphate for Oral Suspension", "active_ingredients": [{"name": "OSELTAMIVIR PHOSPHATE", "strength": "6 mg/mL"}], "application_number": "ANDA217303", "marketing_category": "ANDA", "marketing_start_date": "20251019", "listing_expiration_date": "20261231"}